P
US10046293B2ActiveUtilityPatentIndex 83

In situ chemical patterning

Assignee: ARIZONA BOARD OF REGENTS A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONPriority: Oct 17, 2012Filed: Oct 17, 2013Granted: Aug 14, 2018
Est. expiryOct 17, 2032(~6.3 yrs left)· nominal 20-yr term from priority
Inventors:WOODBURY NEALJOHNSTON STEPHEN ALBERT
B01J 2219/00722B01J 19/0046B01J 2219/00596C07K 1/047B01J 2219/00725
83
PatentIndex Score
10
Cited by
52
References
19
Claims

Abstract

Provided herein are methods and devices for performing in situ patterned chemistry for synthesizing and preparing peptide arrays. The invention provides a reproducible and scalable platform that can be potentially used to monitor the health of a plurality of individuals.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. An in situ synthesized pseudo random peptide library for use in an immunosignature assay, wherein synthesis of the pseudo random peptide library uses a minimum number of patterned steps to construct the pseudo random peptide library on a substrate, wherein the minimum number of patterned steps (M) is less than the product of the number of different monomer units (R) and the length of the peptide (N) according to
   M<R×N,
 
 comprising: 
 a) determining the minimum number of patterned steps (M), wherein the minimum number of patterned steps (M) is at least 33% of the number of patterned steps needed to construct an uncorrelated set of sequences in the pseudo random peptide library, wherein the peptide library is disease agnostic; 
 b) assigning an activated or inactivated designation to each feature of a patterned step; 
 c) assigning a monomer to each feature that is designated as activated; and 
 d) coupling the monomers at each feature on the substrate that is designated as activated; wherein the monomers are sequentially coupled for the minimum number of patterned steps of (a), thereby providing a pseudo-random array for use in the immunosignature assay. 
 
     
     
       2. The pseudo random peptide library of  claim 1 , wherein said synthesis is photolithography-based. 
     
     
       3. The pseudo random peptide library of  claim 2 , wherein the photolithography-based synthesis comprises a photomask pattern step. 
     
     
       4. The pseudo random peptide library of  claim 3 , wherein the photomasking step photomasks a feature of about 0.5 micron to about 200 microns in diameter and a center-to-center distance of about 1 micron to about 300 microns on center. 
     
     
       5. The pseudo random peptide library of  claim 3 , wherein the number of photomasks needed to construct the peptide library is about 33% to about 95% of the number of photomasks needed to construct a peptide library with an uncorrelated set of sequences. 
     
     
       6. The pseudo random peptide library of  claim 3 , wherein the number of photomasks needed to construct the peptide library is about 51% to about 75% of the number of photomasks needed to construct a peptide library with an uncorrelated set of sequences. 
     
     
       7. The pseudo random peptide library of  claim 3 , wherein the number of photomasks needed to construct the peptide library is about 51% to about 55% of the number of photomasks needed to construct a peptide library with an uncorrelated set of sequences. 
     
     
       8. The pseudo random peptide library of  claim 3 , wherein each feature on each photomask is randomly assigned an activated or inactivated designation. 
     
     
       9. The pseudo random peptide library of  claim 1 , wherein the library comprises at least 10,000 features on the substrate. 
     
     
       10. The pseudo random peptide library of  claim 1 , wherein the library comprises at least 100,000 features on the substrate. 
     
     
       11. The pseudo random peptide library of  claim 1 , wherein the library comprises at least 330,000 features on the substrate. 
     
     
       12. The pseudo random peptide library of  claim 1 , wherein the library comprises at least 1,000,000 features on the substrate. 
     
     
       13. The pseudo random peptide library of  claim 1 , wherein the substrate is selected from the group consisting of arrays, wafers, slides, and beads. 
     
     
       14. The pseudo random peptide library of  claim 1 , wherein the peptides are about 5 amino acids to about 25 amino acids in length. 
     
     
       15. The pseudo random peptide library of  claim 14 , wherein the peptide lengths are not uniform between features. 
     
     
       16. The pseudo random peptide library of  claim 1 , wherein amino acids C, I, T, and M, and optionally Q and E, are not included as amino acids available during peptide synthesis. 
     
     
       17. The pseudo random peptide library of  claim 1 , wherein the activated designation is clear. 
     
     
       18. The pseudo random peptide library of  claim 1 , wherein the inactivated designation is opaque. 
     
     
       19. The pseudo random peptide library of  claim 1 , wherein the coupling of the monomers at each feature forms a linear or a branched structure.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.